Abstract:Glioma stem cells (GSCs) are major contributors to the recurrence and drug resistance of glioblastoma (GBM) and are therefore a key target for GBM treatment. However, due to the therapeutic resistance of GSCs, innovative and efficient clinical treatment tools to eliminate GSCs are urgently needed. Photodynamic therapy (PDT) is a new strategy for killing GSCs because of its high safety and sensitive targeting ability. However, the existing photosensitizers applied to kill GSCs generally lack long-wavelength excitation light with effective tissue penetration, which prevents their effective application in vivo. Hence, a novel near-infrared light (NIR)-activated photosensitive drug was developed from upconversion nanoparticles (UCNPs), Pluronic F127 (F127) and curcumin (Cur) to form UCNPs-F127@Cur. This hybrid nanodrug significantly promoted the apoptosis of GSCs, increased the production of intracellular reactive oxygen species, inhibited the expression of pluripotency-related genes in GSCs, and inhibited the growth of transplanted GSCs into tumors in vivo under 980 nm excitation light. However, UCNPs-F127@Cur did not exert the above anti-GSC effects without excitation by 980 nm light. Transcriptome sequencing analysis revealed that PDT with UCNPs-F127@Cur could cause cell cycle arrest and induce the differentiation of GSCs by suppressing the Wnt-β-catenin and Jak-Stat signaling pathways. In conclusion, we constructed a novel NIR-activated, targeted GSC-killing hybrid nanodrug and elucidated its molecular mechanism, thereby providing a new strategy for the treatment of GBM. UCNPs-F127@Cur activated by NIR light with good tissue penetration were constructed and shown to effectively eliminate GSCs by inducing cell apoptosis, arresting cell cycle progression and the self-renewal of GSCs both in vivo and in vitro.

Curcumin Promotes Differentiation of Glioma‐initiating Cells by Inducing Autophagy

Induction Of Autophagy Promotes Differentiation Of Glioma-Initiating Cells And Their Radiosensitivity

Hmga2 Sustains Self-Renewal and Invasiveness of Glioma-Initiating Cells

Curcumin Induces Glioma Stem-Like Cell Formation

Curcumin Induces G2/M Cell Cycle Arrest in A P53-Dependent Manner and Upregulates Ing4 Expression in Human Glioma

Autophagy Suppresses Self-Renewal Ability and Tumorigenicity of Glioma-Initiating Cells and Promotes Notch1 Degradation

Curcumin Suppresses Malignant Glioma Cells Growth and Induces Apoptosis by Inhibition of SHH/GLI1 Signaling Pathway in Vitro and Vivo.

Disruption of β-catenin-mediated negative feedback reinforces cAMP-induced neuronal differentiation in glioma stem cells

Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression

Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling.

Inhibitory effect of curcumin on the proliferation of malignant glioma cells U87 by inducing autophagy

Near-infrared Light-Activatable Upconversion Nanoparticle/curcumin Hybrid Nanodrug: a Potent Strategy to Induce the Differentiation and Elimination of Glioma Stem Cells

MicroRNA-378 Enhances Inhibitory Effect of Curcumin on Glioblastoma

Anticancer Mechanism of Curcumin on Human Glioblastoma

Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells

ABCG2 Downregulation in Glioma Stem Cells Enhances the Therapeutic Efficacy of Demethoxycurcumin

BIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells

Progression of Differentiation Induction in Glioma Therapies

Curcumin Suppresses Cell Growth And Invasion And Induces Apoptosis By Down-Regulation Of Skp2 Pathway In Glioma Cellse

Curcumin-Loaded Layered Double Hydroxide Nanoparticles-Induced Autophagy for Reducing Glioma Cell Migration and Invasion